Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | NQO2 | P16083 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2314445 | 0.76 | MAPT (0.35) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL456729 | 0.74 | CYP2A6 (0.46) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL455449 | 0.73 | ALDH1A1 (0.32) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL458135 | 0.73 | CYP2A6 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL3952850 | 0.73 | CYP1A2 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL75079 | 0.73 | ALDH1A1 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL457801 | 0.73 | CYP2A6 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL9720823 | 0.73 | CYP2A6 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL458019 | 0.73 | CYP2A6 (0.44) | ALDH1A1GLAMAPTHPGDACHE | |
| SCHEMBL2256003 | 0.71 | ALDH1A1 (0.39) | ALDH1A1MAPTCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112175178-B | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-112175178-A | Polycarbonate and preparation method and application thereof | 万华化学集团股份有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-20060079499-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | WU JING | 2006-04-13 | — | — | US | disclosed |
| US-20050182046-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | WU JING (US) | 2005-08-18 | — | — | US | disclosed |
| US-6683075-B1 | FUSED NITROGENHETEROCYCLIC AMIDES; ALZHEIMER'S DISEASE | ATHENA NEUROSCIENCES, INC. | 2004-01-27 | — | — | US | disclosed |
| US-6632811-B2 | Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell | ATHENA NEUROSCIENCES, INC. | 2003-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079499-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | BACE1, APP, BACE2 | ALDH1A1 3897/4885GLA 24/4885MAPT 34/4885 |
| US-20050182046-A1 | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | BACE1, APP, BACE2 | ALDH1A1 3897/4885GLA 24/4885MAPT 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.